BA.2, driven to near-zero levels by BA.5, still haunt us, spawning monstrous viruses that, after vanishing for months, burst forth, gnarled & hideous, in novel antibody armor. The latest, which I found skulking around India, has 13 spike mutations. 1/28 github.com/cov-lineages/p…
There have been just 4 sequences so far, but they’ve been in Indian cities roughly 800-1300 km apart from each other. Spike mutations consist of three deletions + 10 amino acid substitutions, two of which (K478T & R493Q) are reversions. 2/28
Most of these mutations are familiar, & known for their antibody-evading properties. The most unique are the K478T reversion & R1091H, an uncommon S2 mutation. But in this thread, I want to discuss the three new deletions, all in the amino-terminal domain (NTD). 3/28
The NTD, at spike-protein amino acid (AA) sites 14-306, is possibly the most variable region in the SARS-CoV-2 genome, but the reasons for NTD mutations are usually less clear than for the receptor-binding domain (RBD, sites 331-528). 5/28
The RBD binds the ACE2 receptor on human cells & is the primary target of neutralizing antibodies, & most mutations there can be attributed to the effect they have on ACE2 affinity and/or antibody evasion. 6/28
The NTD is, to a lesser extent, also targeted by antibodies, primarily at the NTD antigenic supersite. The NTD contains five loops that extend outward, known as N1, N2, N3, N4, & N5. Loops N1, N3, & N5 largely form the NTD supersite. 7/28
At precisely what amino acid sites are these NTD loops located?
• N1 Loop—14-26
• N2 Loop—67-81
• N3 Loop—140-158
• N4 Loop—174-188
• N5 Loop—241-263 embopress.org/doi/full/10.15…
8/28
As described below, SARS-CoV-2’s NTD loops are long compared to those of other sarbecoviruses, especially N2, N3, & N5. It is precisely at these loops that we see the vast majority of NTD deletions in SARS-CoV-2. 9/28
NTD deletions, by shortening the length of these projecting loops, can help SARS-CoV-2 evade antibodies, a fact first proven by @mccarthy_kr. He showed this, impressively, before any VOC with deletions had yet emerged. 10/28 science.org/doi/10.1126/sc…
But there is more to these NTD deletions than just immune evasion. The most common deletion has been ∆69-70—found in Alpha, BA.1, BA.4/5, & others—and it plays little to no role in immune evasion. 11/28
Variations in NTD-loop length through deletions & insertions turn out to be common in other sarbecoviruses, suggesting their broad utility at facilitating evolutionary change, possibly by compensating for changes caused by mutations elsewhere. 12/28
For example, @GuptaR_lab found that ∆69-70 usually accompanied RBD mutations (like N439K &Y453F) that strengthen ACE2 binding and/or evade immunity but which also reduce viral infectivity. 13/28
∆69-70, inserted into pseudoviruses, increased infectivity & when H69/V70 residues were re-inserted back into Alpha, cell entry, S1/S2 spike cleavage (an essential step in entry), & ability to fuse cells (form syncytia) were all greatly impaired. 14/28
More generally, deletions that shorten NTD loops appear to greatly increase the ability of SARS-CoV-2 to fuse with cell membranes, infect cells, and fuse cells together. 15/28
SARS1 has much shorter NTD loops than SARS2. @EnyaQing found that replacing the SARS2 NTD with the SARS1 NTD in virus-like particles (VLP) enormously increases its ability to fuse with cell membranes and infect cells. 16/28
Similar results were found by @GroveLab when replacing SARS-CoV-2’s NTD with that of Pangolin CoV, which has very short NTD loops. 17/28
By exposing VLP’s to dissolved ACE2 receptors, one can determine the degree to which RBDs are in the exposed “up” position, which is necessary for binding ACE2. The more a VLP is inhibited from fusing w/cell-like particles by dissolved ACE2, the greater the RBD exposure. 18/28
It turns out that by this measure, SARS-CoV-1 NTD—which, again, has much shorter NTD loops than SARS-CoV-2 & is therefore a good proxy for SARS-CoV-2 viruses bearing many deletions—enhances RBD exposure. 19/28
So if shorter NTD loops improves cell entry, fusion with cell membranes, the ability to fuse cells together (syncytia formation), and RBD exposure, why don’t all SARS-CoV-2 have large deletions, shortening their NTD loops? 20/28
NTD deletions must exact a cost, & that cost is spike-protein instability. Putting the SARS2+SARS1-NTD VLP’s through a mildly stressful procedure resulted in the loss of the S1 portion of spike, destroying cell entry & fusion capability. 21/28
So NTD deletions often confer antibody-evading powers and can powerfully increase a virus’s ability to infect cells and fuse cells together, but this comes at the cost of spike instability, leaving it vulnerable to permanent inactivation. 22/28
What determines whether a given NTD deletion will be deleterious or advantageous? The environment of course, most powerfully, the spike protein background. “The impact of NTD hypervariability depends on the S protein background.” 23/28
In fact, it was only after the D614G mutation stabilized spike that NTD deletions became possible. The authors of this study—which is impossible to do justice to here—issued an ominous & prescient warning (written in May 2021, before Delta’s properties were known). 24/28
“That a genetic drift around metastable set points can potentially generate hyper-fusogenic CoVs with enhanced cell entry potential is an important consideration in understanding CoV cell entry, transmission, & pathogenicity.” Indeed. 25/28
Will this particular BA.2 monstrosity, or any of the others, turn out to be hyper-fusogenic, with Delta-like disease severity? My guess is not simply because they retain the Omicron S2, which seems to annihilate all fusogenicity. 26/28
But a reversion to greater fusogenicity, LRT tropism, & Delta-like disease severity seems extremely likely at some point. We would do well to acknowledge this & recognize the necessity of instituting serious NPIs when it happens. 27/28
As usual, I want to emphasize that I’m not an expert in these matters and have no formal credentials. It’s entirely possible I’ve misinterpreted something in this thread, and I welcome corrections and comments from all. 28/28
Finally, thank you to all the hard-working scientists throughout the world sequencing & uploading virus sequences, without which surveillance would be impossible—@r_karyakarte, for example. And thanks to @GISAID for organizing & storing these sequences so they can be monitored.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
BA.3.2 emerged in Nov 2024 after ~3 years of intrahost evolution with >50 new spike AA muts, but since then, it's changed very little. Could the drug molnupiravir (MOV) galvanize BA.3.2 into pursuing new evolutionary paths? A new 89-mut MOV BA.3.2 seq suggests it could. 1/11
Background on MOV: It's a mutagenic drug. Its purpose is to cause so many mutations that the virus becomes unviable & is cleared. But we've long known this often does not happen. Instead, the virus persists in highly mutated form & can be transmitted. 2/
I was an author on a paper published in @Nature that conclusively showed not only that MOV has created highly mutated, persistent viruses, but that these viruses have transmitted numerous times. See 🧵 below by lead author @theosanderson. 3/
The most valuable viral research tools—@nextstrain & CovSpectrum—are being destroyed, not only blocked from new data but now forbidden from even sharing info from the PAST. Why?
Because GISAID is run dictatorially by a con man, paranoid egomaniac, & liar named Peter Bogner. 1/
I use CovSpectrum & Nextstrain every day—& I'm not the only one. Every Covid thread I've ever posted here has relied partly on CovSpectrum & Nextstrain for information & visuals. These vital tools have now been stolen from us by a world-class grifter. 2/ thinkglobalhealth.org/article/to-fin…
For years scientists knew something was very, very wrong with GISAID, but the breakout story (from which much of this 🧵is based) came 2 years ago in @ScienceMagazine from @sciencecohen & Martin Enserik. 3/ science.org/content/articl…
3/77 sequences from the latest Netherlands upload are BA.3.2 as well as 4/86 seqs from Queensland, Australia, consistent w/the steady, slow growth we've seen in Germany, the UK, Ireland, & much of Australia. 1/4
One interesting (and possibly coincidental) aspect of the BA.3.2 tree: Two large branches have NSP14 mutations at adjacent AA residues—ORF1b:T1896I and ORF1b:H1897Y. 2/4
I don't have any idea what functional effects either of these mutations would have. They are both C->T mutations, which is the most common type, but they've been relatively uncommon throughout the pandemic, with fewer than 8000 sequences combined. 3/4
The first instance involved a small cluster of sequences that hospitalized several people & resulted in the death of a young child in early 2022. More on this one later. 2/15
The most recent example requires some background. In late 2024, a spectacularly mutated Delta appeared in Spain with 40 new spike mutations and numerous Cryptic markers.
Normally, I would write a thread about such a remarkable sequence, but there were some issues... 3/15
@StuartTurville has pointed out that WA delayed Covid spread longer than elsewhere in Australia. China has a somewhat similar immune history (as do other SE Asian countries). Perhaps BA.3.2 will do well in China once it arrives there? 2/4
I beg to differ! If it is not a sequencing mistake—and it looks clean—one of these BA.3.2 has something completely novel in SARS-CoV-2 evolution: an FCS-adjacent deletion!
One of the two QT repeats appears to have been deleted. I've never seen anything like this before.
Work by @TheMenacheryLab looked at a similar, more extensive, deletion. They deleted both QT repeats plus the next AA (∆QTQTN). In Vero cells (monkey kidney cells), it produced extra-large plaques & outcompeted WT virus—similar to furin cleavage site (FCS)-deletion mutants. 2/12
But in human lung cancer (Calu3) cells, the ∆QTQTN-mutant replication was dramatically reduced (2.5 orders of magnitude), and in infected hamsters disease was much milder. 3/12